| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
|
Clin Cancer Res
|
2011
|
0.95
|
|
2
|
Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
|
J Dermatol Sci
|
2012
|
0.92
|
|
3
|
Prevalent LIPH founder mutations lead to loss of P2Y5 activation ability of PA-PLA1alpha in autosomal recessive hypotrichosis.
|
Hum Mutat
|
2010
|
0.91
|
|
4
|
Serum gastrin-releasing peptide levels correlate with pruritus in patients with atopic dermatitis.
|
J Invest Dermatol
|
2013
|
0.91
|
|
5
|
TOX expression in different subtypes of cutaneous lymphoma.
|
Arch Dermatol Res
|
2014
|
0.89
|
|
6
|
Hair shaft abnormalities in localized autosomal recessive hypotrichosis 2 and a review of other non-syndromic human alopecias.
|
Acta Derm Venereol
|
2011
|
0.89
|
|
7
|
Lichen planus-like lesions as the first manifestation of adult T-cell leukaemia/lymphoma.
|
Acta Derm Venereol
|
2013
|
0.87
|
|
8
|
Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens.
|
J Invest Dermatol
|
2011
|
0.85
|
|
9
|
Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma.
|
Acta Derm Venereol
|
2012
|
0.83
|
|
10
|
A case of systemic sclerosis with sarcoidosis.
|
Acta Derm Venereol
|
2011
|
0.80
|
|
11
|
Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
|
J Invest Dermatol
|
2012
|
0.79
|
|
12
|
Serum levels of angiopoietin-2, but not angiopoietin-1, are elevated in patients with erythrodermic cutaneous T-cell lymphoma.
|
Acta Derm Venereol
|
2014
|
0.79
|
|
13
|
Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis.
|
Acta Derm Venereol
|
2014
|
0.78
|
|
14
|
Serum-soluble herpes virus entry mediator levels reflect disease severity and Th2 environment in cutaneous T-cell lymphoma.
|
Acta Derm Venereol
|
2013
|
0.75
|
|
15
|
Differential patterns of CXCR3, CCR3, and CCR10 expression in mycosis fungoides, Sezary syndrome and CD30(+) lymphoproliferative disorders: immunohistochemical study of 43 samples.
|
J Dermatol Sci
|
2011
|
0.75
|
|
16
|
Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma.
|
Arch Dermatol Res
|
2012
|
0.75
|
|
17
|
Varicella-like generalized pustulosis induced by adalimumab.
|
Int J Dermatol
|
2013
|
0.75
|
|
18
|
Peripheral T cell lymphoma, not otherwise specified, showing multiple ulcers on the extremities.
|
Int J Dermatol
|
2013
|
0.75
|
|
19
|
Increased Interleukin-19 Expression in Cutaneous T-Cell Lymphoma and Atopic Dermatitis.
|
Acta Derm Venereol
|
2017
|
0.75
|
|
20
|
Placental Growth Factor and Vascular Endothelial Growth Factor Together Regulate Tumour Progression via Increased Vasculature in Cutaneous T Cell Lymphoma.
|
Acta Derm Venereol
|
2017
|
0.75
|
|
21
|
CD8(+) aggressive lymphoma in a human T-cell leukaemia virus type-1 carrier.
|
J Dermatol
|
2014
|
0.75
|